EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020
This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.
Filter the list
|
show/hide
Methanaminium, N-(4-(amino(4-(dimethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-methyl-, dodecyl(sulfophenoxy)benzenesulfonate (2:1)
EC / List no:
-
| CAS no:
63428-09-1
4,4'-bis[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo][1,1'-biphenyl]-2,2'-disulphonic acid, compound with 4,4'-carbonimidoylbis[N,N-dimethylphenylamine] (1:2)
EC / List no:
277-106-0
| CAS no:
72939-51-6
Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, mono(dodecylbenzenesulfonate)
EC / List no:
-
| CAS no:
82794-01-2
Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, 2-hydroxyethanesulfonate
EC / List no:
-
| CAS no:
86157-51-9
Benzenesulfonic acid, 4-dodecyl-, compd. with 4,4'-carbonimidoylbis(N,N-dimethylbenzenamine) (1:1)
EC / List no:
-
| CAS no:
63589-43-5
Decyl hydrogen sulphate, compound with 4,4'-carbonimidoylbis[N,N-dimethylaniline] (1:1)
EC / List no:
281-828-1
| CAS no:
84030-53-5
4,4'-carbonimidoylbis(N,N-dimethylaniline) monohydrochloride
EC / List no:
219-567-2
| CAS no:
2465-27-2
Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, (2-methoxyethoxy)acetate
EC / List no:
-
| CAS no:
82941-28-4
|
-
|
-
|
Carc. 2; Acute Tox. 4; Eye Irrit. 2 |
Details | ||
|
-
|
-
|
Carc. 1B; Acute Tox. 4 |
Details | |||
|
show/hide
(1,1'-Biphenyl)-4,4'-diamine, 3,3'-dimethoxy-, monohydrochloride
EC / List no:
-
| CAS no:
111984-09-9
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, bis(3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-38-8
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, mono(3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-53-7
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, bis(2-hydroxy-3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-49-1
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, mono(2-hydroxy-3,5-dinitrobenzoate)
EC / List no:
-
| CAS no:
92415-48-0
|
-
|
-
|
Carc. 1B; Acute Tox. 4 |
Details | ||
|
-
|
-
|
Carc. 1B; Acute Tox. 4; Skin Sens. 1 |
Details | |||
|
show/hide
|
-
|
-
|
Carc. 1A; Acute Tox. 4 |
Details | ||
|
-
|
-
|
Acute Tox. 4; Eye Dam. 1 |
Details | |||
|
show/hide
Tris(2-hydroxyethyl)ammonium (o,p-dichlorophenoxy)acetate
EC / List no:
219-911-1
| CAS no:
2569-01-9
1-[bis(2-hydroxypropyl)amino]propan-2-ol;2-(2,4-dichlorophenoxy)acetic acid
EC / List no:
639-766-1
| CAS no:
18584-79-7
Acetic acid, (2,4-dichlorophenoxy)-, compd. with 2-[2-[2-(octadecylamino)ethoxy]ethoxy]ethanol(1:1)
EC / List no:
-
| CAS no:
37937-04-5
|
-
|
-
|
Acute Tox. 4; Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
-
|
-
|
Carc. 1B; Acute Tox. 4 |
Details | |||
|
-
|
-
|
Acute Tox. 4 |
Details | |||
|
-
|
-
|
Acute Tox. 4 |
Details | |||
|
show/hide
|
-
|
-
|
Repr. 1B; Acute Tox. 2; Acute Tox. 3 |
Details | ||
|
show/hide
2-sec-butyl-4,6-dinitrophenol, compound with 2,2'-iminodiethanol (1:1)
EC / List no:
258-532-6
| CAS no:
53404-43-6
2-sec-butyl-4,6-dinitrophenol, compound with 2,2',2''-nitrilotriethanol (1:1)
EC / List no:
229-166-4
| CAS no:
6420-47-9
2-sec-butyl-4,6-dinitrophenol, compound with 1-aminopropan-2-ol (1:1)
EC / List no:
275-931-0
| CAS no:
71735-19-8
|
-
|
-
|
Repr. 1B; Acute Tox. 3; Eye Irrit. 2 |
Details | ||
|
-
|
-
|
Acute Tox. 3 |
Details | |||
|
-
|
-
|
Acute Tox. 3 |
Details | |||
|
-
|
-
|
Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
Details | |||
|
425-210-3
|
169939-84-8
|
Skin Sens. 1 |
Details | |||
|
-
|
68583-35-7
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
200-712-3
|
69-72-7
|
Repr. 2; Acute Tox. 4; Eye Dam. 1 |
Details | |||
|
202-345-4
|
94-59-7
|
Carc. 1B; Muta. 2; Acute Tox. 4 |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
617-100-0
|
8051-02-3
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
Details | |||
|
618-004-1
|
87392-12-9
|
Skin Sens. 1 |
Details | |||
|
243-193-9
|
19622-19-6
|
Acute Tox. 4 |
Details | |||
|
249-013-5
|
28434-00-6
|
Acute Tox. 4 |
Details | |||
|
-
|
2635-50-9
|
Acute Tox. 3 |
Details | |||
|
620-370-2
|
2703-37-9
|
Acute Tox. 2; Acute Tox. 1 |
Details | |||
|
-
|
953-17-3
|
Acute Tox. 3 |
Details | |||
|
ALKYL ISOCYANATE SILANE SCD 617
|
402-290-8
|
85702-90-5
|
Flam. Liq. 3; Resp. Sens. 1; Skin Sens. 1 |
Details | ||
|
436-690-9
|
220727-26-4
|
Skin Sens. 1 |
Details | |||
|
R-GLYCIDOL
|
404-660-4
|
57044-25-4
|
Self-react. C; Carc. 1B; Muta. 2; Repr. 1B; Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B |
Details | ||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
Skin Sens. 1 |
Details | |||
|
A complex combination derived from wood, especially pine wood. Composed primarily of resin acids and modified resin acids such as dimers and decarboxylated resin acids. Includes rosin stabilized by catalytic disproportionation.
|
232-475-7
|
8050-09-7
|
Skin Sens. 1 |
Details | ||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||
|
-
|
-
|
B Bacteria and similar species |
Details | |||